227 related articles for article (PubMed ID: 24528518)
1. Interactions between malaria and human immunodeficiency virus anno 2014.
Van Geertruyden JP
Clin Microbiol Infect; 2014 Apr; 20(4):278-85. PubMed ID: 24528518
[TBL] [Abstract][Full Text] [Related]
2. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women.
Natureeba P; Ades V; Luwedde F; Mwesigwa J; Plenty A; Okong P; Charlebois ED; Clark TD; Nzarubara B; Havlir DV; Achan J; Kamya MR; Cohan D; Dorsey G
J Infect Dis; 2014 Dec; 210(12):1938-45. PubMed ID: 24958908
[TBL] [Abstract][Full Text] [Related]
3. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.
Achan J; Kakuru A; Ikilezi G; Ruel T; Clark TD; Nsanzabana C; Charlebois E; Aweeka F; Dorsey G; Rosenthal PJ; Havlir D; Kamya MR
N Engl J Med; 2012 Nov; 367(22):2110-8. PubMed ID: 23190222
[TBL] [Abstract][Full Text] [Related]
5. Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults.
Byakika-Kibwika P; Lamorde M; Okaba-Kayom V; Mayanja-Kizza H; Katabira E; Hanpithakpong W; Pakker N; Dorlo TP; Tarning J; Lindegardh N; de Vries PJ; Back D; Khoo S; Merry C
J Antimicrob Chemother; 2012 May; 67(5):1217-23. PubMed ID: 22316571
[TBL] [Abstract][Full Text] [Related]
6. An Individual Participant Data Population Pharmacokinetic Meta-analysis of Drug-Drug Interactions between Lumefantrine and Commonly Used Antiretroviral Treatment.
Francis J; Barnes KI; Workman L; Kredo T; Vestergaard LS; Hoglund RM; Byakika-Kibwika P; Lamorde M; Walimbwa SI; Chijioke-Nwauche I; Sutherland CJ; Merry C; Scarsi KK; Nyagonde N; Lemnge MM; Khoo SH; Bygbjerg IC; Parikh S; Aweeka FT; Tarning J; Denti P
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071050
[TBL] [Abstract][Full Text] [Related]
7. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.
Brentlinger PE; Behrens CB; Micek MA
Lancet Infect Dis; 2006 Feb; 6(2):100-11. PubMed ID: 16439330
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals.
Kiang TK; Wilby KJ; Ensom MH
Clin Pharmacokinet; 2014 Feb; 53(2):141-53. PubMed ID: 24158666
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.
Banda CG; Dzinjalamala F; Mukaka M; Mallewa J; Maiden V; Terlouw DJ; Lalloo DG; Khoo SH; Mwapasa V
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760133
[TBL] [Abstract][Full Text] [Related]
12. The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.
Kredo T; Mauff K; Workman L; Van der Walt JS; Wiesner L; Smith PJ; Maartens G; Cohen K; Barnes KI
BMC Infect Dis; 2016 Jan; 16():30. PubMed ID: 26818566
[TBL] [Abstract][Full Text] [Related]
13. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
Mermin J; Ekwaru JP; Liechty CA; Were W; Downing R; Ransom R; Weidle P; Lule J; Coutinho A; Solberg P
Lancet; 2006 Apr; 367(9518):1256-61. PubMed ID: 16631881
[TBL] [Abstract][Full Text] [Related]
14. Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy.
Banda CG; Dzinjalamala F; Mukaka M; Mallewa J; Maiden V; Terlouw DJ; Lalloo DG; Khoo SH; Mwapasa V
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150465
[TBL] [Abstract][Full Text] [Related]
15. HIV and malaria: interactions and implications.
Slutsker L; Marston BJ
Curr Opin Infect Dis; 2007 Feb; 20(1):3-10. PubMed ID: 17197875
[TBL] [Abstract][Full Text] [Related]
16. The epidemiological impact of HIV antiretroviral therapy on malaria in children.
Greenhalgh S; Ndeffo M; Galvani AP; Parikh S
AIDS; 2015 Feb; 29(4):473-82. PubMed ID: 25486414
[TBL] [Abstract][Full Text] [Related]
17. Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria.
Usman SO; Oreagba IA; Akinyede AA; Agbaje EO; Akinleye MO; Onwujuobi AG; Ken-Owotor C; Adeuja O; Ogunfowokan T; Kogbe S; Owolabi ET; Adeniji H; Busari AW; Hassan OO; Abideen G; Akanmu AS
J Pharmacol Sci; 2020 Nov; 144(3):95-101. PubMed ID: 32921396
[TBL] [Abstract][Full Text] [Related]
18. Disease and drug interactions: treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infection.
Olliaro P
Clin Infect Dis; 2008 Apr; 46(7):992-3. PubMed ID: 18444814
[No Abstract] [Full Text] [Related]
19. Brief Report: Antimalarial Benefit of HIV Antiretroviral Therapy in Areas of Low to Moderate Malaria Transmission Intensity.
Greenhalgh S; Hobbs CV; Parikh S
J Acquir Immune Defic Syndr; 2018 Oct; 79(2):249-254. PubMed ID: 30212437
[TBL] [Abstract][Full Text] [Related]
20. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
